ACTA1 and renal fibrosis: In a mouse model of ischemic AKI, local delivery of BMSC-EVs by SAP hydrogels showed better efficacy in decreasing renal damage, inflammation and subsequent renal fibrosis (α-SMA and FN) than EVs alone (154).